111 related articles for article (PubMed ID: 37858174)
1. Correction: NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells.
Xu Y; Nasri M; Dannenmann B; Mir P; Zahabi A; Welte K; Morishima T; Skokowa J
Stem Cell Res Ther; 2023 Oct; 14(1):299. PubMed ID: 37858174
[No Abstract] [Full Text] [Related]
2. NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells.
Xu Y; Nasri M; Dannenmann B; Mir P; Zahabi A; Welte K; Morishima T; Skokowa J
Stem Cell Res Ther; 2021 Feb; 12(1):112. PubMed ID: 33546767
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway.
Grohmann T; Penke M; Petzold-Quinque S; Schuster S; Richter S; Kiess W; Garten A
Leuk Res; 2018 Jun; 69():39-46. PubMed ID: 29653431
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of P/CAF, as a ubiquitin ligase toward MDM2, suppresses mitotic cell death through p53-p21 activation in HCT116 cells with SIRT2 suppression.
Li Y; Kokura K; Inoue T
Biochem Biophys Res Commun; 2019 Jan; 508(1):230-236. PubMed ID: 30482390
[TBL] [Abstract][Full Text] [Related]
5. Sirtuin 2 expression suppresses oxidative stress and senescence of nucleus pulposus cells through inhibition of the p53/p21 pathway.
Yang M; Peng Y; Liu W; Zhou M; Meng Q; Yuan C
Biochem Biophys Res Commun; 2019 Jun; 513(3):616-622. PubMed ID: 30981502
[TBL] [Abstract][Full Text] [Related]
6. Tenovin-D3, a novel small-molecule inhibitor of sirtuin SirT2, increases p21 (CDKN1A) expression in a p53-independent manner.
McCarthy AR; Sachweh MC; Higgins M; Campbell J; Drummond CJ; van Leeuwen IM; Pirrie L; Ladds MJ; Westwood NJ; Laín S
Mol Cancer Ther; 2013 Apr; 12(4):352-60. PubMed ID: 23322738
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide phosphoribosyl transferase regulates cell growth via the Sirt1/P53 signaling pathway and is a prognosis marker in colorectal cancer.
Pan JH; Zhou H; Zhu SB; Huang JL; Zhao XX; Ding H; Qin L; Pan YL
J Cell Physiol; 2019 Apr; 234(4):4385-4395. PubMed ID: 30191976
[TBL] [Abstract][Full Text] [Related]
8. Regulation of SIRT2 by Wnt/β-catenin signaling pathway in colorectal cancer cells.
Li C; Zhou Y; Kim JT; Sengoku T; Alstott MC; Weiss HL; Wang Q; Evers BM
Biochim Biophys Acta Mol Cell Res; 2021 Apr; 1868(4):118966. PubMed ID: 33450304
[TBL] [Abstract][Full Text] [Related]
9. Notch1 activation reduces proliferation in the multipotent hematopoietic progenitor cell line FDCP-mix through a p53-dependent pathway but Notch1 effects on myeloid and erythroid differentiation are independent of p53.
Henning K; Heering J; Schwanbeck R; Schroeder T; Helmbold H; Schäfer H; Deppert W; Kim E; Just U
Cell Death Differ; 2008 Feb; 15(2):398-407. PubMed ID: 18049480
[TBL] [Abstract][Full Text] [Related]
10. Expression and sequence of canine SIRT2 and p53 genes in canine mammary tumour cells - effects on downstream targets Wip1 and p21/Cip1.
DeInnocentes P; Li LX; Sanchez RL; Bird RC
Vet Comp Oncol; 2006 Sep; 4(3):161-77. PubMed ID: 19754813
[TBL] [Abstract][Full Text] [Related]
11. LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis.
Morishima T; Krahl AC; Nasri M; Xu Y; Aghaallaei N; Findik B; Klimiankou M; Ritter M; Hartmann MD; Gloeckner CJ; Stefanczyk S; Lindner C; Oswald B; Bernhard R; Hähnel K; Hermanutz-Klein U; Ebinger M; Handgretinger R; Casadei N; Welte K; Andre M; Müller P; Bajoghli B; Skokowa J
Blood; 2019 Oct; 134(14):1159-1175. PubMed ID: 31366618
[TBL] [Abstract][Full Text] [Related]
12. A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer.
Hoffmann G; Breitenbücher F; Schuler M; Ehrenhofer-Murray AE
J Biol Chem; 2014 Feb; 289(8):5208-16. PubMed ID: 24379401
[TBL] [Abstract][Full Text] [Related]
13. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.
Hong H; Takahashi K; Ichisaka T; Aoi T; Kanagawa O; Nakagawa M; Okita K; Yamanaka S
Nature; 2009 Aug; 460(7259):1132-5. PubMed ID: 19668191
[TBL] [Abstract][Full Text] [Related]
14. The SIRT2 Pathway Is Involved in the Antiproliferative Effect of Flavanones in Human Leukemia Monocytic THP-1 Cells.
Russo C; Maugeri A; De Luca L; Gitto R; Lombardo GE; Musumeci L; De Sarro G; Cirmi S; Navarra M
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289647
[TBL] [Abstract][Full Text] [Related]
15. Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells.
Thakur BK; Dittrich T; Chandra P; Becker A; Kuehnau W; Klusmann JH; Reinhardt D; Welte K
Int J Cancer; 2013 Feb; 132(4):766-74. PubMed ID: 22815158
[TBL] [Abstract][Full Text] [Related]
16. SIRT2 inhibition exacerbates p53-mediated ferroptosis in mice following experimental traumatic brain injury.
Gao J; Li Y; Song R
Neuroreport; 2021 Aug; 32(12):1001-1008. PubMed ID: 34102645
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of human papillomavirus, Epstein-Barr virus, p21, and p53 expression in sinonasal inverted papilloma, nasal polyp, and hypertrophied turbinate in Hong Kong patients.
Sham CL; To KF; Chan PK; Lee DL; Tong MC; van Hasselt CA
Head Neck; 2012 Apr; 34(4):520-33. PubMed ID: 21608063
[TBL] [Abstract][Full Text] [Related]
18. SIRT2 Contributes to the Regulation of Intestinal Cell Proliferation and Differentiation.
Li C; Zhou Y; Rychahou P; Weiss HL; Lee EY; Perry CL; Barrett TA; Wang Q; Evers BM
Cell Mol Gastroenterol Hepatol; 2020; 10(1):43-57. PubMed ID: 31954883
[TBL] [Abstract][Full Text] [Related]
19. Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53.
Jin YH; Kim YJ; Kim DW; Baek KH; Kang BY; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2008 Apr; 368(3):690-5. PubMed ID: 18249187
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocyte Differentiation Promotes Cell Survival During Nicotinamide Phosphoribosyltransferase Inhibition Through Increased Maintenance of Cellular Energy Stores.
Kropp EM; Broniowska KA; Waas M; Nycz A; Corbett JA; Gundry RL
Stem Cells Transl Med; 2017 Apr; 6(4):1191-1201. PubMed ID: 28224719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
